Moderna Says RSV Vaccine Is 84% Effective at Preventing Disease in Older Adults

January 18, 2023

(CNBC) – The vaccine was 83.7% effective at preventing lower respiratory tract disease, defined as two or more symptoms, in people ages 60 and older, according to the Boston biotech company. It was 82.4% effective at preventing lower respiratory tract disease with three or more symptoms. (Read More)